COSMOS Pharmaceutical Corporation

TSE:3349 주식 리포트

시가총액: JP¥510.1b

COSMOS Pharmaceutical 향후 성장

Future 기준 점검 2/6

COSMOS Pharmaceutical (는) 각각 연간 5.1% 및 7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 5.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 10.5% 로 예상됩니다.

핵심 정보

5.1%

이익 성장률

5.08%

EPS 성장률

Consumer Retailing 이익 성장7.7%
매출 성장률7.0%
향후 자기자본이익률10.47%
애널리스트 커버리지

Good

마지막 업데이트15 Sep 2026

최근 향후 성장 업데이트

분석 기사 • Jul 15

Analysts Have Been Trimming Their COSMOS Pharmaceutical Corporation (TSE:3349) Price Target After Its Latest Report

Shareholders might have noticed that COSMOS Pharmaceutical Corporation ( TSE:3349 ) filed its annual result this time...
분석 기사 • Apr 15

COSMOS Pharmaceutical Corporation (TSE:3349) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Last week, you might have seen that COSMOS Pharmaceutical Corporation ( TSE:3349 ) released its quarterly result to the...
분석 기사 • Jan 15

COSMOS Pharmaceutical Corporation (TSE:3349) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

There's been a notable change in appetite for COSMOS Pharmaceutical Corporation ( TSE:3349 ) shares in the week since...
분석 기사 • Oct 16

COSMOS Pharmaceutical Corporation Just Missed EPS By 8.0%: Here's What Analysts Think Will Happen Next

COSMOS Pharmaceutical Corporation ( TSE:3349 ) shareholders are probably feeling a little disappointed, since its...
분석 기사 • Jul 16

Here's What Analysts Are Forecasting For COSMOS Pharmaceutical Corporation (TSE:3349) After Its Annual Results

Last week, you might have seen that COSMOS Pharmaceutical Corporation ( TSE:3349 ) released its annual result to the...
분석 기사 • Apr 16

COSMOS Pharmaceutical Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Investors in COSMOS Pharmaceutical Corporation ( TSE:3349 ) had a good week, as its shares rose 8.8% to close at...

Recent updates

분석 기사 • Jul 15

Analysts Have Been Trimming Their COSMOS Pharmaceutical Corporation (TSE:3349) Price Target After Its Latest Report

Shareholders might have noticed that COSMOS Pharmaceutical Corporation ( TSE:3349 ) filed its annual result this time...
분석 기사 • Apr 15

COSMOS Pharmaceutical Corporation (TSE:3349) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Last week, you might have seen that COSMOS Pharmaceutical Corporation ( TSE:3349 ) released its quarterly result to the...
분석 기사 • Feb 16

COSMOS Pharmaceutical (TSE:3349) Seems To Use Debt Quite Sensibly

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Jan 15

COSMOS Pharmaceutical Corporation (TSE:3349) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

There's been a notable change in appetite for COSMOS Pharmaceutical Corporation ( TSE:3349 ) shares in the week since...
분석 기사 • Nov 28

Returns On Capital Signal Tricky Times Ahead For COSMOS Pharmaceutical (TSE:3349)

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
분석 기사 • Nov 13

COSMOS Pharmaceutical (TSE:3349) Will Pay A Dividend Of ¥37.50

COSMOS Pharmaceutical Corporation's ( TSE:3349 ) investors are due to receive a payment of ¥37.50 per share on 12th of...
분석 기사 • Nov 12

Does COSMOS Pharmaceutical (TSE:3349) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Oct 27

COSMOS Pharmaceutical's (TSE:3349) Dividend Will Be ¥37.50

The board of COSMOS Pharmaceutical Corporation ( TSE:3349 ) has announced that it will pay a dividend on the 12th of...
분석 기사 • Oct 16

COSMOS Pharmaceutical Corporation Just Missed EPS By 8.0%: Here's What Analysts Think Will Happen Next

COSMOS Pharmaceutical Corporation ( TSE:3349 ) shareholders are probably feeling a little disappointed, since its...
분석 기사 • Sep 17

Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio

With a price-to-earnings (or "P/E") ratio of 22.8x COSMOS Pharmaceutical Corporation ( TSE:3349 ) may be sending very...
분석 기사 • Aug 15

Here's Why We Think COSMOS Pharmaceutical (TSE:3349) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
분석 기사 • Jul 16

Here's What Analysts Are Forecasting For COSMOS Pharmaceutical Corporation (TSE:3349) After Its Annual Results

Last week, you might have seen that COSMOS Pharmaceutical Corporation ( TSE:3349 ) released its annual result to the...
분석 기사 • Jul 04

Return Trends At COSMOS Pharmaceutical (TSE:3349) Aren't Appealing

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
분석 기사 • Jun 02

Is COSMOS Pharmaceutical (TSE:3349) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • May 17

Investor Optimism Abounds COSMOS Pharmaceutical Corporation (TSE:3349) But Growth Is Lacking

With a price-to-earnings (or "P/E") ratio of 24.7x COSMOS Pharmaceutical Corporation ( TSE:3349 ) may be sending very...
분석 기사 • Apr 16

COSMOS Pharmaceutical Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Investors in COSMOS Pharmaceutical Corporation ( TSE:3349 ) had a good week, as its shares rose 8.8% to close at...
분석 기사 • Mar 27

Should You Be Adding COSMOS Pharmaceutical (TSE:3349) To Your Watchlist Today?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
분석 기사 • Mar 11

COSMOS Pharmaceutical's (TSE:3349) Returns On Capital Not Reflecting Well On The Business

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Jan 31

COSMOS Pharmaceutical Corporation's (TSE:3349) Business Is Yet to Catch Up With Its Share Price

With a price-to-earnings (or "P/E") ratio of 21.5x COSMOS Pharmaceutical Corporation ( TSE:3349 ) may be sending very...
분석 기사 • Jan 17

COSMOS Pharmaceutical Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shareholders of COSMOS Pharmaceutical Corporation ( TSE:3349 ) will be pleased this week, given that the stock price is...
분석 기사 • Dec 25

Here's Why COSMOS Pharmaceutical (TSE:3349) Can Manage Its Debt Responsibly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Nov 18

COSMOS Pharmaceutical's (TSE:3349) Returns On Capital Not Reflecting Well On The Business

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Sep 26

We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Aug 17

An Intrinsic Calculation For COSMOS Pharmaceutical Corporation (TSE:3349) Suggests It's 41% Undervalued

Key Insights The projected fair value for COSMOS Pharmaceutical is JP¥23,011 based on 2 Stage Free Cash Flow to Equity...
분석 기사 • Aug 01

COSMOS Pharmaceutical (TSE:3349) Will Want To Turn Around Its Return Trends

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
분석 기사 • Jun 28

Subdued Growth No Barrier To COSMOS Pharmaceutical Corporation's (TSE:3349) Price

COSMOS Pharmaceutical Corporation's ( TSE:3349 ) price-to-earnings (or "P/E") ratio of 20.7x might make it look like a...
분석 기사 • Jun 10

We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Apr 17

COSMOS Pharmaceutical Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

It's been a good week for COSMOS Pharmaceutical Corporation ( TSE:3349 ) shareholders, because the company has just...
분석 기사 • Mar 16

Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio

With a price-to-earnings (or "P/E") ratio of 23.3x COSMOS Pharmaceutical Corporation ( TSE:3349 ) may be sending very...
분석 기사 • Feb 28

Returns On Capital At COSMOS Pharmaceutical (TSE:3349) Paint A Concerning Picture

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...

이익 및 매출 성장 예측

TSE:3349 - 애널리스트 향후 추정치 및 과거 재무 데이터 (JPY Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
5/31/20291,369,82136,374-63380,2158
5/31/20281,271,78834,113-2,90073,69010
5/31/20271,182,34432,103-7,90068,16210
5/31/20261,099,58332,046-11,67258,790N/A
2/28/20261,069,50231,383N/AN/AN/A
11/30/20251,042,62931,198-46259,529N/A
8/31/20251,021,94331,006N/AN/AN/A
5/31/20251,011,39030,978-85952,467N/A
2/28/20251,001,94629,440N/AN/AN/A
11/30/2024994,49527,2953,53553,314N/A
8/31/2024985,17726,089N/AN/AN/A
5/31/2024964,98924,454-63555,175N/A
2/29/2024936,70624,871N/AN/AN/A
11/30/2023900,11124,08568154,534N/A
8/31/2023863,22823,824N/AN/AN/A
5/31/2023827,69723,7977,79854,434N/A
2/28/2023802,83122,983N/AN/AN/A
11/30/2022788,29223,209-3,65541,973N/A
8/31/2022772,12723,393N/AN/AN/A
5/31/2022755,41423,155-11,30332,194N/A
2/28/2022743,61222,030N/AN/AN/A
11/30/2021733,38725,329-535,596N/A
8/31/2021726,67225,909N/AN/AN/A
5/31/2021726,42427,1561,81127,875N/A
2/28/2021733,22328,777N/AN/AN/A
11/30/2020723,30925,73628,88250,935N/A
8/31/2020709,06423,876N/AN/AN/A
5/31/2020684,40321,43539,51365,461N/A
2/29/2020653,52720,217N/AN/AN/A
11/30/2019638,03418,951N/A38,209N/A
8/31/2019622,10319,349N/AN/AN/A
5/31/2019611,13719,185N/A34,379N/A
2/28/2019597,71518,966N/AN/AN/A
11/30/2018585,53618,857N/A30,947N/A
8/31/2018572,80717,880N/AN/AN/A
5/31/2018557,99917,633N/A32,586N/A
2/28/2018542,93617,510N/AN/AN/A
11/30/2017526,52317,313N/A35,488N/A
8/31/2017514,88018,239N/AN/AN/A
5/31/2017502,73218,215N/A36,938N/A
2/28/2017490,03715,812N/AN/AN/A
11/30/2016477,73914,981N/A34,300N/A
8/31/2016463,51713,679N/AN/AN/A
5/31/2016447,27312,435N/A30,986N/A
2/29/2016433,32812,738N/AN/AN/A
11/30/2015423,81712,474N/A22,426N/A

애널리스트 향후 성장 전망

수입 대 저축률: 3349 의 연간 예상 수익 증가율(5.1%)이 saving rate(0.9%)보다 높습니다.

수익 vs 시장: 3349 의 연간 수익(5.1%)이 JP 시장(8.9%)보다 느리게 성장할 것으로 예상됩니다.

고성장 수익: 3349 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: 3349 의 수익(연간 7%)이 JP 시장(연간 6.4%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: 3349 의 수익(연간 7%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: 3349의 자본 수익률은 3년 후 10.5%로 낮을 것으로 예상됩니다.

성장 기업 찾아보기

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/09/20 23:09
종가2026/09/18 00:00
수익2026/05/31
연간 수익2026/05/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.

Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

COSMOS Pharmaceutical Corporation는 18명의 분석가가 다루고 있습니다. 이 중 10명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Arashi NishizawaBofA Global Research
Citi ResearchCitigroup Inc
Mitsuru TakayanagiCitigroup Inc